Prognostic Factors in the Non-Hodgkin's Lymphomas--a Time for Consensus?

Overview

Journal Br J Cancer

Specialty Oncology

Date 1991 Jun 1

PMID 2069841

Citations 1

Authors

J A Child

Affiliations

Soon will be listed here.

Citing Articles

Non-Hodgkin's lymphomas in Turkey: eighteen years' experience at the Hacettepe University.

Barista I, Tekuzman G, Firat D, Baltali E, Kansu E, Kars A Jpn J Cancer Res. 1994; 85(12):1200-7.

PMID: 7531679 PMC: 5919392. DOI: 10.1111/j.1349-7006.1994.tb02930.x.

References

Carbone P, Kaplan H, MUSSHOFF K, SMITHERS D, TUBIANA M . Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971; 31(11):1860-1. View

BIERMAN H, Hill B, Reinhardt L, EMORY E . Correlation of serum lactic dehydrogenase activity with the clinical status of patients with cancer, lymphomas, and the leukemias. Cancer Res. 1957; 17(7):660-7. View

Cabanillas F, Burke J, Smith T, MOON T, Butler J, Rodriguez V . Factors predicting for response and survival in adults with advanced non-Hodgkin's lymphoma. Arch Intern Med. 1978; 138(3):413-8. View

Ferraris A, Giuntini P, Gaetani G . Serum lactic dehydrogenase as a prognostic tool for non-Hodgkin lymphomas. Blood. 1979; 54(4):928-32. View

Child J, Spati B, Illingworth S, Barnard D, Corbett S, Simmons A . Serum beta 2 microglobulin and C-reactive protein in the monitoring of lymphomas: findings in a multicenter study and experience in selected patients. Cancer. 1980; 45(2):318-26. DOI: 10.1002/1097-0142(19800115)45:2<318::aid-cncr2820450220>3.0.co;2-c. View

Simonsson B, Nilsson K . 3H-thymidine uptake in chronic lymphocytic leukaemia cells. Scand J Haematol. 1980; 24(2):169-73. DOI: 10.1111/j.1600-0609.1980.tb02363.x. View

Schneider R, Seibert K, Passe S, Little C, Gee T, Lee 3rd B . Prognostic significance of serum lactate dehydrogenase in malignant lymphoma. Cancer. 1980; 46(1):139-43. DOI: 10.1002/1097-0142(19800701)46:1<139::aid-cncr2820460122>3.0.co;2-8. View

Spati B, Child J, Kerruish S, Cooper E . Behaviour of serum beta 2-microglobulin and acute phase reactant proteins in chronic lymphocytic leukaemia. A multicentre study. Acta Haematol. 1980; 64(2):79-86. DOI: 10.1159/000207215. View

Costa A, Bonadonna G, Villa E, Valagussa P, Silvestrini R . Labeling index as a prognostic marker in non-Hodgkin's lymphomas. J Natl Cancer Inst. 1981; 66(1):1-5. View

10.

Diamond L, Nathwani B, Rappaport H . Flow cytometry in the diagnosis and classification of malignant lymphoma and leukemia. Cancer. 1982; 50(6):1122-35. DOI: 10.1002/1097-0142(19820915)50:6<1122::aid-cncr2820500616>3.0.co;2-q. View

11.

Hagberg H, Killander A, Simonsson B . Serum beta 2-microglobulin in malignant lymphoma. Cancer. 1983; 51(12):2220-5. DOI: 10.1002/1097-0142(19830615)51:12<2220::aid-cncr2820511212>3.0.co;2-a. View

12.

Anderson H, Scarffe J, Swindell R, Crowther D . Serum beta 2-microglobulin in patients with non-Hodgkin's lymphoma. Eur J Cancer Clin Oncol. 1983; 19(3):327-31. DOI: 10.1016/0277-5379(83)90129-3. View

13.

Brittinger G, Bartels H, Common H, Duhmke E, Fulle H, Gunzer U . Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group. Hematol Oncol. 1984; 2(3):269-306. DOI: 10.1002/hon.2900020306. View

14.

Gerdes J, DALLENBACH F, Lennert K, Lemke H, STEIN H . Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Hematol Oncol. 1984; 2(4):365-71. DOI: 10.1002/hon.2900020406. View

15.

Child J, Kushwaha M . Serum beta 2-microglobulin in lymphoproliferative and myeloproliferative diseases. Hematol Oncol. 1984; 2(4):391-401. DOI: 10.1002/hon.2900020409. View

16.

Tsujimoto Y, Cossman J, Jaffe E, Croce C . Involvement of the bcl-2 gene in human follicular lymphoma. Science. 1985; 228(4706):1440-3. DOI: 10.1126/science.3874430. View

17.

Levine E, Arthur D, Frizzera G, Peterson B, Hurd D, Bloomfield C . There are differences in cytogenetic abnormalities among histologic subtypes of the non-Hodgkin's lymphomas. Blood. 1985; 66(6):1414-22. View

18.

Roos G, Dige U, Lenner P, Lindh J, Johansson H . Prognostic significance of DNA-analysis by flow cytometry in non-Hodgkin's lymphoma. Hematol Oncol. 1985; 3(4):233-42. DOI: 10.1002/hon.2900030403. View

19.

Armitage J, Weisenburger D, Hutchins M, MORAVEC D, Dowling M, Sorensen S . Chemotherapy for diffuse large-cell lymphoma--rapidly responding patients have more durable remissions. J Clin Oncol. 1986; 4(2):160-4. DOI: 10.1200/JCO.1986.4.2.160. View

20.

Jagannath S, Velasquez W, Tucker S, Fuller L, McLaughlin P, Manning J . Tumor burden assessment and its implication for a prognostic model in advanced diffuse large-cell lymphoma. J Clin Oncol. 1986; 4(6):859-65. DOI: 10.1200/JCO.1986.4.6.859. View